Tacrolimus-induced hypertension: What's endothelial and hematopoietic FKBP12 got to do with it?

Hypertension

Volumn 57, Issue 6, 2011, Pages 1058-1060

  Didion, Sean P ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CRE RECOMBINASE; CYCLOSPORIN A; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN; FKBP12 PROTEIN; IMMUNOPHILIN; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 6; STAT3 PROTEIN; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; C57BL 6 MOUSE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL POLARITY; CELL PROLIFERATION; CLINICAL ASSESSMENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INDUCED DISEASE; ENDOTHELIAL DYSFUNCTION; FLOW CYTOMETRY; GENE DELETION; GRAFT REJECTION; HELPER CELL; HEMATOPOIETIC CELL; HUMAN; HYPERTENSION; INFUSION; LOXP SITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; REVIEW; SPLEEN CELL; SYSTOLIC BLOOD PRESSURE; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; THORACIC AORTA; TRANSGENIC MOUSE; VASODILATATION;

ANIMALS; BLOOD CELLS; CYTOKINES; ENDOTHELIAL CELLS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, KNOCKOUT; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD2 PROTEIN; SMAD3 PROTEIN; T-LYMPHOCYTES, REGULATORY; TACROLIMUS; TACROLIMUS BINDING PROTEIN 1A; TH17 CELLS;

EID: 79956374358     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.172320     Document Type: Review

References (10)

1. Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA. 2000;283:633-638. (Pubitemid 30069179)
2. The US Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cylcosporine for immunosuppression in liver transplantation. N Engl J Med. 1994;331:1110-1115.
3. Kasiske BL, Anjum S, Shah R, Skogen J, Kandaswamy C, Danielson B, O'Shaughnessy EA, Dahl DC, Silkensen JR, Sahadevan M, Synder JJ. Hypertension after kidney transplantation. Am J Kidney Dis. 2004;43: 1071-1081. (Pubitemid 38691503)
4. Tocci MJ, Matkovich DA, Collier KA, Kwok P, Dumont F, Lin S, Degudicibus S, Siekierka JJ, Chin J, Hutchinson NI. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol. 1989;143:718-726. (Pubitemid 19191575)
5. Chiasson VL, Talreja D, Young KJ, Chatterjee P, Banes-Berceli AK, Mitchell BM. FK506 binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension. Hypertension. 2011;57:1167-1175.
6. Schrader LI, Kinzenbaw DA, Johnson AW, Faraci FM, Didion SP. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Arterioscler Thromb Vasc Biol. 2007;27:2576-2581. (Pubitemid 350158908)
7. Takeda Y, Miyamori I, Furukawa K, Inaba S, Mabuchi H. Mechanisms of FK 506-induced hypertension in the rat. Hypertension. 1999;33:130-136. (Pubitemid 29061853)
8. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239-242.
9. Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ, Harrison DG. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension. 2010;55:500-507.
10. Saura M, Zaragoza C, Bao C, Herranz B, Rodriquez-Puyol M, Lowenstein CJ. Stat3 mediates interleukin-6 inhibition of human endothelial nitric-oxide synthase expression. J Biol Chem. 2006;281:30057-30062. (Pubitemid 44537013)